Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2

被引：7

作者：

Ahn, Terrie S. ^{[1
]}

Han, Brandon ^{[2
,3
]}

Krogstad, Paul ^{[2
,4
]}

Bun, Chantana ^{[1
]}

Kohn, Lisa A. ^{[1
]}

Garcia-Lloret, Maria I. ^{[1
]}

Damoiseaux, Robert ^{[2
,3
,5
]}

Butte, Manish J. ^{[1
,6
]}

机构：

[1] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90024 USA

[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA USA

[4] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA

[5] Univ Calif Los Angeles, Dept Bioengn, Samueli Sch Engn, Los Angeles, CA USA

[6] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 03期

关键词：

INTRAVENOUS IMMUNOGLOBULIN;

D O I：

10.1016/j.jaci.2020.12.003

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：876 / 877

页数：2

共 7 条

[1] High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 [J].

Cao, Wei ;

Liu, Xiaosheng ;

Bai, Tao ;

Fan, Hongwei ;

Hong, Ke ;

Song, Hui ;

Han, Yang ;

Lin, Ling ;

Ruan, Lianguo ;

Li, Taisheng .

OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03) :1-6

[2] Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens [J].

Diez, Jose-Maria ;

Romero, Carolina ;

Gajardo, Rodrigo .

IMMUNOTHERAPY, 2020, 12 (08) :571-576

[3] Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity in Intravenous Immunoglobulin as a Potential Therapeutic Against Emerging Influenza Viruses [J].

Jegaskanda, Sinthujan ;

Vandenberg, Kirsten ;

Laurie, Karen L. ;

Loh, Liyen ;

Kramski, Marit ;

Winnall, Wendy R. ;

Kedzierska, Katherine ;

Rockman, Steven ;

Kent, Stephen J. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (11) :1811-1822

[4] Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome(MERS): A review [J].

Mustafa, Sabeena ;

Balkhy, Hanan ;

Gabere, Musa N. .

JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (01) :9-17

[5] Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19 [J].

Shi, Hua ;

Zhou, Chaomin ;

He, Pinghong ;

Huang, Sheng ;

Duan, Youjun ;

Wang, Xuesheng ;

Lin, Kexiong ;

Zhou, Chao ;

Zhang, Xiangyan ;

Zha, Yan .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)

[6] Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19 [J].

Xie, Yun ;

Cao, Song ;

Dong, Hui ;

Li, Qingyun ;

Chen, Erzhen ;

Zhang, Wenkai ;

Yang, Luyu ;

Fu, Shouzhi ;

Wang, Ruilan .

JOURNAL OF INFECTION, 2020, 81 (02) :340-343

[7] A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV [J].

Yuan, Meng ;

Wu, Nicholas C. ;

Zhu, Xueyong ;

Lee, Chang-Chun D. ;

So, Ray T. Y. ;

Lv, Huibin ;

Mok, Chris K. P. ;

Wilson, Ian A. .

SCIENCE, 2020, 368 (6491) :630-+

← 1 →